1,747
Views
69
CrossRef citations to date
0
Altmetric
Comprehensive review

The human-microbiome superorganism and its modulation to restore health

ORCID Icon
Pages 781-795 | Received 02 Nov 2018, Accepted 06 Feb 2019, Published online: 07 Mar 2019

References

  • Aanen DK, Eggleton P. 2017. Symbiogenesis: beyond the endosymbiosis theory? J Theor Biol. 434:99–103.
  • Aggarwal J, Swami G, Kumar M. 2013. Probiotics and their effects on metabolic diseases: an update. J Clin Diagn Res. 7:173–177.
  • Agusti A, Moya-Pérez A, Campillo I, Montserrat-de la Paz S, Cerrudo V, Perez-Villalba A, Sanz Y. 2018. Bifidobacterium pseudocatenulatum CECT 7765 ameliorates neuroendocrine alterations associated with an exaggerated stress response and anhedonia in obese mice. Mol Neurobiol. 55:5337–5352.
  • Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. 2013. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 138:155–175.
  • Al-Sheraji SH, Ismail A, Manap MY, Mustafa S, Yusof RM, Hassan FA. 2013. Prebiotics as functional foods: a review. J Funct Foods. 5:1542–1553.
  • Arrieta M-C, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. 2014. The intestinal microbiome in early life: health and disease. Front Immunol. 5:427.
  • Bagarolli RA, Tobar N, Oliveira AG, Araújo TG, Carvalho BM, Rocha GZ, Vecina JF, Calisto K, Guadagnini D, Prada PO, et al. 2017. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice. J Nutr Biochem. 50:16–25.
  • Bager P, Arnved J, Rønborg S, Wohlfahrt J, Poulsen LK, Westergaard T, Petersen HW, Kristensen B, Thamsborg S, Roepstorff A, et al. 2010. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol. 125:123–130.e1–3.
  • Bak SH, Choi HH, Lee J, Kim MH, Lee YH, Kim JS, Cho Y-S. 2017. Fecal microbiota transplantation for refractory Crohn's disease. Intest Res. 15:244–248.
  • Bakhtiar SM, LeBlanc JG, Salvucci E, Ali A, Martin R, Langella P, Chatel JM, Miyoshi A, Bermúdez-Humarán LG, Azevedo V. 2013. Implications of the human microbiome in inflammatory bowel diseases. FEMS Microbiol Lett. 342:10–17.
  • Baquero F, Nombela C. 2012. The microbiome as a human organ. Clin Microbiol Infect. 18(Suppl. 4):2–4.
  • Bell PJL. 2009. The viral eukaryogenesis hypothesis: a key role for viruses in the emergence of eukaryotes from a prokaryotic world environment. Ann NY Acad Sci. 1178:91–105.
  • Benson AK. 2016. The gut microbiome—an emerging complex trait. Nat Genet. 48:1301–1302.
  • Bercik P, Collins SM, Verdu EF. 2012. Microbes and the gut-brain axis. Neurogastroenterol Motil. 24:405–413.
  • Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, et al.etal. 2011. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication. Neurogastroenterol Motil. 23:1132–1139.
  • Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, et al. 2010. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 139:2102–2112.e1.
  • Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. 2005. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 100:1539–1546.
  • Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. 2014. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 20:509–518.
  • Broekaert WF, Courtin CM, Verbeke K, Van de Wiele T, Verstraete W, Delcour JA. 2011. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr. 51:178–194.
  • Brucker RM, Bordenstein SR. 2012. Speciation by symbiosis. Trends Ecol Evol (Amst). 27:443–451.
  • Cano PG, Santacruz A, Trejo FM, Sanz Y. 2013. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity (Silver Spring MD). 21:2310–2321.
  • Cavalier-Smith T. 1992. Symbiosis as a source of evolutionary innovation: speciation and morphogenesis: edited by Lynn Margulis and René Fester, MIT Press, 1991. £33.75 hbk (xiii + 454 pages) ISBN 0 262 13269 9. Trends Ecol Evol. 7:422–423.
  • Chang Q, Khare G, Dani V, Nelson S, Jaenisch R. 2006. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron. 49:341–348.
  • Chapleau CA, Larimore JL, Theibert A, Pozzo-Miller L. 2009. Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. J Neurodev Disord. 1:185–196.
  • Chuong EB, Elde NC, Feschotte C. 2017. Regulatory activities of transposable elements: from conflicts to benefits. Nat Rev Genet. 18:71–86.
  • Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. 2014. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol (Baltim MD). 28:1221–1238.
  • Collins SM, Surette M, Bercik P. 2012. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 10:735–742.
  • Colson P, Levasseur A, La Scola B, Sharma V, Nasir A, Pontarotti P, Caetano-Anollés G, Raoult D. 2018. Ancestrality and mosaicism of giant viruses supporting the definition of the fourth TRUC of microbes. Front Microbiol. 9:2668.
  • Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. 2016. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 5:e73.
  • Correia CT, Coutinho AM, Sequeira AF, Sousa IG, Lourenço Venda L, Almeida JP, Abreu RL, Lobo C, Miguel TS, Conroy J, et al. 2010. Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes Brain Behav. 9:841–848.
  • Croese J, O’Neil J, Masson J, Cooke S, Melrose W, Pritchard D, Speare R. 2006. A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors. Gut. 55:136–137.
  • Cryan JF, Dinan TG. 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 13:701–712.
  • Cui L, Morris A, Ghedin E. 2013. The human mycobiome in health and disease. Genome Med. 5:63.
  • Davis CD. 2016. The gut microbiome and its role in obesity. Nutr Today. 51:167–174.
  • de Theije CGM, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R. 2014. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun. 37:197–206.
  • Degano AL, Park MJ, Penati J, Li Q, Ronnett GV. 2014. MeCP2 is required for activity-dependent refinement of olfactory circuits. Mol Cell Neurosci. 59:63–75.
  • Dotterud CK, Storrø O, Johnsen R, Øien T. 2010. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 163:616–623.
  • Durzyńska J, Goździcka-Józefiak A. 2015. Viruses and cells intertwined since the dawn of evolution. Virol J. 12:169.
  • Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. 2017. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 8:1784.
  • Enaud R, Vandenborght L-E, Coron N, Bazin T, Prevel R, Schaeverbeke T, Berger P, Fayon M, Lamireau T, Delhaes L. 2018. The mycobiome: a neglected component in the microbiota-gut-brain axis. Microorganisms. 6:1.
  • Evans JM, Morris LS, Marchesi J. 2013. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol.218:R37–R47.
  • Feary JR, Venn AJ, Mortimer K, Brown AP, Hooi D, Falcone FH, Pritchard DI, Britton JR. 2010. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy. 40:299–306.
  • Feschotte C. 2008. Transposable elements and the evolution of regulatory networks. Nat Rev Genet. 9:397–405.
  • Flint HJ. 2012. The impact of nutrition on the human microbiome. Nutr Rev. 70:S10–S13.
  • Foley KA, Ossenkopp K-P, Kavaliers M, MacFabe DF. 2014. Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLoS One. 9:e87072.
  • Foster JA, McVey Neufeld K-A. 2013. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36:305–312.
  • Frye RE, Rose S, Chacko J, Wynne R, Bennuri SC, Slattery JC, Tippett M, Delhey L, Melnyk S, Kahler SG, et al. 2016. Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. Transl Psychiatry. 6:e927.
  • Fugmann SD. 2010. The origins of the Rag genes-from transposition to V(D)J recombination. Semin Immunol. 22:10–16.
  • Fujimori S, Gudis K, Mitsui K, Seo T, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C. 2009. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 25:520–525.
  • Georgiades K, Raoult D. 2011. The rhizome of Reclinomonas americana, Homo sapiens, Pediculus humanus and Saccharomyces cerevisiae mitochondria. Biol Direct. 6:55.
  • Gianotti RJ, Moss AC. 2017. Fecal microbiota transplantation: from clostridium difficile to inflammatory bowel disease. Gastroenterol Hepatol (NY). 13:209–213.
  • Gilbert SF, McDonald E, Boyle N, Buttino N, Gyi L, Mai M, Prakash N, Robinson J. 2010. Symbiosis as a source of selectable epigenetic variation: taking the heat for the big guy. Philos Trans R Soc Lond B Biol Sci. 365:671–678.
  • Grimaldi R, Gibson GR, Vulevic J, Giallourou N, Castro-Mejía JL, Hansen LH, Leigh Gibson E, Nielsen DS, Costabile A. 2018. A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome. 6:133.
  • Halepoto D, Bahir S, Al-Ayadhi LY. 2014. Possible role of brain-derived neurotrophic factor (BDNF) in autism spectrum disorder: current status. J Coll Phys Surg. 24:274–278.
  • Hallen-Adams HE, Suhr MJ. 2017. Fungi in the healthy human gastrointestinal tract. Virulence. 8:352–358.
  • Hattori M, Taylor TD. 2009. The human intestinal microbiome: a new frontier of human biology. DNA Res. 16:1–12.
  • Hayley S, Audet M-C, Anisman H. 2016. Inflammation and the microbiome: implications for depressive disorders. Curr Opin Pharmacol. 29:42–46.
  • Hemalatha R, Ouwehand AC, Saarinen MT, Prasad UV, Swetha K, Bhaskar V. 2017. Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2–5-year-old children. Microb Ecol Health Dis. 28:1298340.
  • Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, et al. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 155:1451–1463.
  • Hunter MM, McKay DM. 2004. Review article: helminths as therapeutic agents for inflammatory bowel disease. Aliment Pharmacol Ther. 19:167–177.
  • Iliev ID, Leonardi I. 2017. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 17:635–646.
  • Jablonka E, Raz G. 2009. Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol. 84:131–176.
  • Jones BV. 2010. The human gut mobile metagenome: a metazoan perspective. Gut Microbes. 1:415–431.
  • Kao D, Hotte N, Gillevet P, Madsen K. 2014. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol. 48:625–628.
  • Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I. 2015. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients. 7:2839–2849.
  • Katz DM. 2014. Brain-derived neurotrophic factor and Rett syndrome. Handb Exp Pharmacol. 220:481–495.
  • Koleva PT, Bridgman SL, Kozyrskyj AL. 2015. The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients. 7:2237–2260.
  • Kozo-Polyansky BM, Margulis L. 2010. Symbiogenesis: a new principle of evolution. Fet V, translator. Cambridge, MA: Paperbackshop UK Import.
  • Kramer P, Bressan P. 2015. Humans as superorganisms: how microbes, viruses, imprinted genes, and other selfish entities shape our behavior. Perspect Psychol Sci. 10:464–481.
  • Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. 2007. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 119:192–198.
  • Lane N. 2017. Serial endosymbiosis or singular event at the origin of eukaryotes? J Theor Biol. 434:58–67.
  • Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L. 2009. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis. 34:199–211.
  • Lee YY, Chua ASB. 2011. Influence of gut microbes on the brain-gut axis (Gut 2011;60:307–317). J Neurogastroenterol Motil. 17:427–429.
  • Levasseur A, Merhej V, Baptiste E, Sharma V, Pontarotti P, Raoult D. 2017. The rhizome of Lokiarchaeota illustrates the mosaicity of archaeal genomes. Genome Biol Evol. 9:2635–2639.
  • Li Q, Han Y, Dy ABC, Hagerman RJ. 2017. The gut microbiota and autism spectrum disorders. Front Cell Neurosci. 11:120.
  • MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP.etal.2007. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 176:149–169.
  • MacFabe DF. 2012. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 23:10.3402.
  • Manichanh C, Reeder J, Gibert P, Varela E, Llopis M, Antolin M, Guigo R,etal. Knight R, Guarner F. 2010. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res. 20:1411–1419.
  • Margulis L, Chapman MJ. 1998. Endosymbioses: cyclical and permanent in evolution. Trends Microbiol. 6:342–345, discussion 345–346.
  • Margulis L, Fester R. 1991. Bellagio Conference and Book. Symbiosis as Source of Evolutionary Innovation: Speciation and Morphogenesis. Conference; June 25–30, 1989; Bellagio Conference Center, Italy. Symbiosis 11. p. 93–101.
  • Marini E, Maldonado-Contreras AL, Cabras S, Hidalgo G, Buffa R, Marin A, Floris G, Racugno W, Pericchi LR, Castellanos ME, et al. 2007. Helicobacter pylori and intestinal parasites are not detrimental to the nutritional status of Amerindians. Am J Trop Med Hyg. 76:534–540.
  • Martín R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, et al. 2017. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: a step forward in the use of F. prausnitzii as a next-generation probiotic. Front Microbiol. 8:1226.
  • Martinez C, Andres F, Balciunas EM, Manuel Salgado J, Gonzalez D, Manuel J, Converti A, Souza Olivera RP. 2013. Lactic acid properties, applications and production: a review. Trends Food Sci Technol. 30:70.
  • Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 122:107–118.
  • McInerney J, Pisani D, O'Connell MJ. 2015. The ring of life hypothesis for eukaryote origins is supported by multiple kinds of data. Philos Trans R Soc Lond B Biol Sci. 370:20140323.
  • McKeown RE. 2009. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med. 3:19S–26S.
  • McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, Ruyssers NE, Speare R, McCarthy JS, Engwerda CR, et al. 2011. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS ONE. 6:e24092.
  • Merhej V, Raoult D. 2012. Rhizome of life, catastrophes, sequence exchanges, gene creations, and giant viruses: how microbial genomics challenges Darwin. Front Cell Infect Microbiol. 2:113.
  • Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, Stewart CJ, et al. 2017. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 5:153.
  • Nicolucci AC, Hume MP, Martínez I, Mayengbam S, Walter J, Reimer RA. 2017. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology. 153:711–722.
  • O’Sullivan E, Barrett E, Grenham S, Fitzgerald P, Stanton C, Ross RP, Quigley EM, Cryan JF, Dinan TG. 2011. BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels? Benef Microbes. 2:199–207.
  • Obregon-Tito AJ, Tito RY, Metcalf J, Sankaranarayanan K, Clemente JC, Ursell LK, Zech Xu Z, Van Treuren W, Knight R, Gaffney PM, et al. 2015. Subsistence strategies in traditional societies distinguish gut microbiomes. Nat Commun. 6:6505.
  • O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. 2015. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 277:32–48.
  • Osborn DA, Sinn JK. 2013. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev.(3):CD006474.
  • Palma ML, Zamith-Miranda D, Martins FS, Bozza FA, Nimrichter L, Montero-Lomeli M, Marques ETA, Douradinha B. 2015. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? Appl Microbiol Biotechnol. 99:6563–6570.
  • Parfrey LW, Walters WA, Knight R. 2011. Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions. Front Microbiol. 2:153.
  • Pastell H, Westermann P, Meyer AS, Tuomainen P, Tenkanen M. 2009. In vitro fermentation of arabinoxylan-derived carbohydrates by bifidobacteria and mixed fecal microbiota. J Agric Food Chem. 57:8598–8606.
  • Paun A, Danska JS. 2015. Immuno-ecology: how the microbiome regulates tolerance and autoimmunity. Curr Opin Immunol. 37:34–39.
  • Rampelli S, Schnorr SL, Consolandi C, Turroni S, Severgnini M, Peano C, Brigidi P, etal.Crittenden AN, Henry AG, Candela M. 2015. Metagenome sequencing of the Hadza hunter-gatherer gut microbiota. Curr Biol. 25:1682–1693.
  • Ramulu HG, Raoult D, Pontarotti P. 2012. The rhizome of life: what about metazoa? Front Cell Infect Microbiol. 2:50.
  • Raoult D. 2010. The post-Darwinist rhizome of life. Lancet. 375:104–105.
  • Reddy A, Fried B. 2009. An update on the use of helminths to treat Crohn's and other autoimmunune diseases. Parasitol Res. 104:217–221.
  • Reynolds LA, Finlay BB, Maizels RM. 2015. Cohabitation in the intestine: interactions among helminth parasites, bacterial microbiota, and host immunity. J Immunol (Baltim MD). 195:4059–4066.
  • Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, et al. 2013. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res. 24:491–501.
  • Rios-Covian D, Arboleya S, Hernandez-Barranco AM, Alvarez-Buylla JR, Ruas-Madiedo P, Gueimonde M, de los Reyes-Gavilan CG. 2013. Interactions between bifidobacterium and bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria. Appl Environ Microbiol. 79:7518–7524.
  • Rivas-Carrillo SD, Pettersson ME, Rubin C-J, Jern P. 2018. Whole-genome comparison of endogenous retrovirus segregation across wild and domestic host species populations. Proc Natl Acad Sci USA. 115:11012–11017.
  • Rivière A, Moens F, Selak M, Maes D, Weckx S, De Vuyst L. 2014. The ability of bifidobacteria to degrade arabinoxylan oligosaccharide constituents and derived oligosaccharides is strain dependent. Appl Environ Microbiol. 80:204–217.
  • Rook GA. 2009. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology. 126:3–11.
  • Rosenberg E, Zilber-Rosenberg I. 2011. Symbiosis and development: the hologenome concept. Birth Defects Res C Embryo Today. 93:56–66.
  • Rosenfeld CS. 2015. Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos Biol Fate Chem. 43:1557–1571.
  • Saad N, Delattre C, Urdaci M, Schmitter JM, Bressollier P. 2013. An overview of the last advances in probiotic and prebiotic field. LWT - Food Sci Technol. 50:1–16.
  • Salvucci E. 2012. Selfishness, warfare, and economics; or integration, cooperation, and biology. Front Cell Infect Microbiol. 2:54.
  • Salvucci E. 2013. Consequences of biome depletion. Acta Biol Colomb. 18:31–42.
  • Salvucci E. 2016. Microbiome, holobiont and the net of life. Crit Rev Microbiol. 42:485–494.
  • Samaco RC, Neul JL. 2011. Complexities of Rett syndrome and MeCP2. J Neurosci. 31:7951–7959.
  • Sanchez JI, Marzorati M, Grootaert C, Baran M, Van Craeyveld V, Courtin CM, Broekaert WF, Delcour JA, Verstraete W, Van de Wiele T. 2009. Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem. Microb Biotechnol. 2:101–113.
  • Sandiego CM, Gallezot J-D, Pittman B, Nabulsi N, Lim K, Lin S-F, Matuskey D, Lee JY, O'Connor KC, Huang Y, et al. 2015. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA. 112:12468–12473.
  • Savignac HM, Corona G, Mills H, Chen L, Spencer JPE, Tzortzis G, Burnet PWJ. 2013. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochem Int. 63:756–764.
  • Savignac HM, Kiely B, Dinan TG, Cryan JF. 2014. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 26:1615–1627.
  • Savinov AB. 2012. Autocenosis and democenosis as symbiotic systems and biological notions. Zhurnal Obshcheĭ Biol. 73:284–301.
  • Schneider KM, Wirtz TH, Kroy D, Albers S, Neumann UP, Strowig T, Sellge G, Trautwein C. 2018. Successful fecal microbiota transplantation in a patient with severe complicated Clostridium difficile infection after liver transplantation. CRG. 12:76–84.
  • Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, Turroni S, Biagi E, Peano C, Severgnini M, et al. 2014. Gut microbiome of the Hadza hunter-gatherers. Nat Commun. 5:3654.
  • Schnorr SL, Sankaranarayanan K, Lewis CM, Warinner C. 2016. Insights into human evolution from ancient and contemporary microbiome studies. Curr Opin Genet Dev. 41:14–26.
  • Schroeder FA, Lin CL, Crusio WE, Akbarian S. 2007. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry. 62:55–64.
  • Sender R, Fuchs S, Milo R. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14:e1002533.
  • Severance EG, Yolken RH, Eaton WW. 2016. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 176:23–35.
  • Singh Y, Ahmad J, Musarrat J, Ehtesham NZ, Hasnain SE. 2013. Emerging importance of holobionts in evolution and in probiotics. Gut Pathog. 5:12.
  • Sleator RD. 2010. The human superorganism – of microbes and men. Med Hypoth. 74:214–215.
  • Smits SA, Leach J, Sonnenburg ED, Gonzalez CG, Lichtman JS, Reid G, Knight R, Manjurano A, Changalucha J, Elias JE, et al. 2017. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science. 357:802–806.
  • Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. 2016. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 529:212–215.
  • Sonnenburg ED, Sonnenburg JL. 2014. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 20:779–786.
  • Strati F, Cavalieri D, Albanese D, Felice CD, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, et al. 2017. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 5:24.
  • Summers RW, Elliott DE, Urban JF, Thompson RA, Weinstock JV. 2005a. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 128:825–832.
  • Summers RW, Elliott DE, Urban JF, Thompson R, Weinstock JV. 2005b. Trichuris suis therapy in Crohn's disease. Gut. 54:87–90.
  • Theoharides TC, Athanassiou M, Panagiotidou S, Doyle R. 2015. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. J Neuroimmunol. 279:33–38.
  • Thomas S, Metzke D, Schmitz J, Dörffel Y, Baumgart DC. 2011. Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 301:G1083–G1092.
  • Tilg H, Kaser A. 2011. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 121:2126–2132.
  • Tito RY, Knights D, Metcalf J, Obregon-Tito AJ, Cleeland L, Najar F, Roe B, Reinhard K, Sobolik K, Belknap S, et al. 2012. Insights from characterizing extinct human gut microbiomes. PLoS ONE. 7:e51146.
  • Tristem M. 2000. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol. 74:3715–3730.
  • Truchado P, Hernandez-Sanabria E, Salden BN, Van den Abbeele P, Vilchez-Vargas R, Jauregui R, Pieper DH, Possemiersa S, Van de Wiele T. 2017. Long chain arabinoxylans shift the mucosa-associated microbiota in the proximal colon of the simulator of the human intestinal microbial ecosystem (M-SHIME). J Funct Foods. 32:226–237.
  • Turroni S, Fiori J, Rampelli S, Schnorr SL, Consolandi C, Barone M, Biagi E, Fanelli F, Mezzullo M, Crittenden A, et al. 2016. Fecal metabolome of the Hadza hunter-gatherers: a host-microbiome integrative view. Sci Rep. 6:32826.
  • van der Meulen TA, Harmsen HJM, Bootsma H, Spijkervet FKL, Kroese FGM, Vissink A. 2016. The microbiome systemic diseases connection. Oral Dis.73:14741–14750.
  • van Zanten GC, Knudsen A, Röytiö H, Forssten S, Lawther M, Blennow A, Lahtinen SJ, Jakobsen M, Svensson B, Jespersen L. 2012. The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PLoS One. 7:e47212.
  • Vandenplas Y, Huys G, Daube G. 2015. Probiotics: an update. J Pediatr (Rio J). 91:6–21.
  • Vangay P, Johnson AJ, Ward TL, Al-Ghalith GA, Shields-Cutler RR, Hillmann BM, Lucas SK, Beura LK, Thompson EA, Till LM, et al. 2018. US immigration westernizes the human gut microbiome. Cell. 175:962–972.e10.
  • Vannier-Santos MA, Lenzi HL. 2011. Parasites or cohabitants: cruel omnipresent usurpers or creative “éminences grises”? J Parasitol Res. 2011:214174.
  • Weinstock JV, Elliott DE. 2013. Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol. 43:245–251.
  • Welters CFM, Heineman E, Thunnissen FBJM, van den Bogaard AEJM, Soeters PB, Baeten CGMI. 2002. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 45:621–627.
  • West CE, Jenmalm MC, Prescott SL. 2015. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 45:43–53.
  • Xu X, Miller EC, Pozzo-Miller L. 2014. Dendritic spine dysgenesis in Rett syndrome. Front Neuroanat. 8:97.
  • Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. 2012. Human gut microbiome viewed across age and geography. Nature. 486:222–227.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.